Form 4: Interparfums CFO Michel Atwood Reports Option Grants

Michel Atwood, CFO of Interparfums Inc, reports the acquisition of options to purchase common stock at various exercise prices and dates.

Summary

• Michel Atwood, the CFO of Interparfums Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
• The report indicates that Atwood acquired options to buy Interparfums' common stock.
• These options have various exercise prices, including $97.84, $147.71 and $130.60.
• The options vest and become exercisable on different dates, spanning from December 31, 2023, to December 31, 2029, and expire on either December 30, 2028, December 28, 2029, or December 30, 2030.
• Atwood directly owns the reported derivative securities.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing detailing option grants, which is neither overtly positive nor negative. The sentiment is neutral.

Positives

• The granting of options to a key executive like the CFO can be seen as an incentive to align their interests with those of the shareholders.

Industry Context

This filing is a routine disclosure related to executive compensation and is common in the industry.

Comparison to Industry Standards

• Option grants are a standard component of executive compensation packages in publicly traded companies, including those in the fragrance and cosmetics industry.
• Companies like Coty Inc. and Estée Lauder also utilize stock options as part of their executive compensation plans.
• The specific terms of these option grants, such as vesting schedules and exercise prices, are typically benchmarked against industry peers to ensure competitiveness.

Stakeholder Impact

• The option grants incentivize the CFO to work towards increasing shareholder value.
• The grants have no immediate impact on employees, customers, suppliers, or creditors.

Key Dates